These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 16116959)
1. Activity of matrix metalloproteinase in airway epithelial cells of COPD patients. Li W; Xu Y; Zhang Z J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):151-4. PubMed ID: 16116959 [TBL] [Abstract][Full Text] [Related]
2. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease]. Kong YJ; Sun WX; Zhang YM; Shi YZ Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786 [TBL] [Abstract][Full Text] [Related]
3. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline. Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608 [TBL] [Abstract][Full Text] [Related]
4. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models]. Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602 [TBL] [Abstract][Full Text] [Related]
5. Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model. Sun J; Bao J; Shi Y; Zhang B; Yuan L; Li J; Zhang L; Sun M; Zhang L; Sun W Int J Chron Obstruct Pulmon Dis; 2017; 12():717-724. PubMed ID: 28260878 [TBL] [Abstract][Full Text] [Related]
6. Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity. Uysal P; Uzun H Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781876 [TBL] [Abstract][Full Text] [Related]
8. [Markers of airway remodeling in induced sputum from healthy smokers]. Avilés B; Belda J; Margarit G; Bellido-Casado J; Martínez-Brú C; Casan P Arch Bronconeumol; 2006 May; 42(5):235-40. PubMed ID: 16740239 [TBL] [Abstract][Full Text] [Related]
9. Effects of Fengbaisan on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats with chronic obstructive pulmonary disease. Wang Y; Su NX; Chen ZQ; Wang Z; Zhang SF Chin J Integr Med; 2014 Mar; 20(3):224-31. PubMed ID: 24242136 [TBL] [Abstract][Full Text] [Related]
10. Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study. Kwiatkowska S; Noweta K; Zieba M; Nowak D; Bialasiewicz P Respiration; 2012; 84(3):231-41. PubMed ID: 22832426 [TBL] [Abstract][Full Text] [Related]
11. Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice. Li W; Shen HH Chin Med J (Engl); 2007 Jan; 120(1):5-11. PubMed ID: 17254480 [TBL] [Abstract][Full Text] [Related]
12. SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD. Yao H; Hwang JW; Sundar IK; Friedman AE; McBurney MW; Guarente L; Gu W; Kinnula VL; Rahman I Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(9):L615-24. PubMed ID: 24039251 [TBL] [Abstract][Full Text] [Related]
13. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease. Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289 [TBL] [Abstract][Full Text] [Related]
15. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients. Hao W; Li M; Zhang C; Zhang Y; Wang P Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512 [No Abstract] [Full Text] [Related]
17. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Beeh KM; Beier J; Kornmann O; Buhl R Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147 [TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer]. Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459 [TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464 [TBL] [Abstract][Full Text] [Related]
20. Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis. Bastos MF; Tucci MA; de Siqueira A; de Faveri M; Figueiredo LC; Vallim PC; Duarte PM J Periodontal Res; 2017 Apr; 52(2):292-299. PubMed ID: 27363729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]